Skip to main content
Log in

Plasmacytoid lymphoma treated with rituximab as first-line monotherapy

  • Correspondence
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Stansfeld AG, Diebold J, Noel H et al (1988) Updated Kiel classification for lymphomas. Lancet 1:292–293 (letter)

    Article  CAS  PubMed  Google Scholar 

  2. Berger F, Felman P, Sonet A et al (1994) Nonfollicular small B-cell lymphomas: a heterogeneous group of patients with distinct clinical features and outcome. Blood 83:2829–2835

    CAS  PubMed  Google Scholar 

  3. Harris NL, Jaffe ES, Stein H et al (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84: 1361–1392

    CAS  PubMed  Google Scholar 

  4. Harris NL, Bhan AK (1985) B-cell neoplasms of the lymphocytic lymphoplasmacytoid, and plasma cell types: immunohistologic analysis and clinical correlation. Hum Pathol 16:829–837

    Article  CAS  PubMed  Google Scholar 

  5. Foran J, Rohatiner A, Coiffier B et al (1999) Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenström’s macroglobulinemia, and mantle-cell lymphoma. J Clin Oncol 17:546–553

    CAS  PubMed  Google Scholar 

  6. Baldini L, Brugiatelli M, Luminari S et al (2003) Treatment of indolent B-cell nonfollicular lymphomas: final results of the LL01 randomized trial of the Gruppo Italiano per lo Studio dei Linfomi. J Clin Oncol 21:1459–1465

    Article  CAS  PubMed  Google Scholar 

  7. Hainsworth JD, Litchy S, Morrissey LH et al (2005) Rituximab plus short-duration chemotherapy as first-line treatment for follicular non- Hodgkin’s lymphoma: a phase II Trial of the Minnie Pearl Cancer Research Network. J Clin Oncol 23:1500–1506

    Article  CAS  PubMed  Google Scholar 

  8. Witzig T, Vukov A, Habermann T et al (2005) Rituximab therapy for patients with newly diagnosed, advanced-stage, follicular grade I non- Hodgkin’s lymphoma: a phase II trial in the North Central Cancer Treatment Group. J Clin Oncol 23:1103–1108

    Article  CAS  PubMed  Google Scholar 

  9. Dimopoulos MA, Alexanian R (1994) Waldenstrom’s macroglobulinemia. Blood 83:1452–1459

    CAS  PubMed  Google Scholar 

  10. Dimopoulos M, Zervas C, Zomas A et al (2002) Treatment of Waldenström’s macroglobulinemia with rituximab. J Clin Oncol 20:2327–2333

    Article  CAS  PubMed  Google Scholar 

  11. Dimopoulos MA, Kyle RA, Anagnostopoulos A et al (2005) Diagnosis and management of Waldenstrom’s macroglobulinemia. J Clin Oncol 23:1564–1577

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to I. Blancas López-Barajas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blancas López-Barajas, I., Zarcos, I., Gómez, F.J. et al. Plasmacytoid lymphoma treated with rituximab as first-line monotherapy. Clin Transl Oncol 11, 704–706 (2009). https://doi.org/10.1007/s12094-009-0429-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-009-0429-4

Keywords

Navigation